Mobilization of Hematopoietic Progenitor Cells for Autologous Transplantation Using Pegfilgrastim and Plerixafor: Efficacy and Cost Implications-Reference-Cited by-同舟云学术

Mobilization of Hematopoietic Progenitor Cells for Autologous Transplantation Using Pegfilgrastim and Plerixafor: Efficacy and Cost Implications

Published:2019-02 Issue:2 Volume:25 Page:233-238
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Watts Nicole L.,Marques Marisa B.,Peavey Daniel B.,Innis-Shelton Racquel,Saad Ayman^ORCID,AD Stasi,Salzman Donna,Lamb Lawrence S.^ORCID,Costa Luciano J.^ORCID

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference34 articles.

1. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants;To;Bone Marrow Transplant,1992

2. Peripheral blood progenitor cell transplantation: a replacement for marrow auto- or allografts;Körbling;Stem Cells,1996

3. Intermediate-dose versus low-dose cyclophosphamide and granulocyte colony-stimulating factor for peripheral blood stem cell mobilization in patients with multiple myeloma treated with novel induction therapies;Hamadani;Biol Blood Marrow Transplant,2012

4. Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation;Pusic;Biol Blood Marrow Transplant,2008

5. Comparison of peripheral blood progenitor cell mobilization in patients with multiple myeloma: high-dose cyclophosphamide plus GM-CSF vs G-CSF alone;Alegre;Bone Marrow Transplant,1997

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comparative review of Aphexda and Mozobil for mobilization prior to stem cell collection;Journal of Oncology Pharmacy Practice;2024-04-17

2. On-demand plerixafor added to high-dose cyclophosphamide and pegylated recombinant human granulocyte colony-stimulating factor in the mobilization of patients with multiple myeloma: a treatment with high effectiveness, convenient, and affordable cost;Frontiers in Oncology;2024-01-17

3. Hematopoietic Cell Collection;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

4. A novel PEGylated form of granulocyte colony-stimulating factor, mecapegfilgrastim, for peripheral blood stem cell mobilization in patients with hematologic malignancies;BMC Cancer;2023-07-24

5. An innovation in stem cell harvesting: Heparin use;Transfusion and Apheresis Science;2021-10